These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6812385)

  • 1. Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period.
    Hagen C; Christensen MS; Christiansen C; Stocklund KE; Transbøl I
    Acta Obstet Gynecol Scand; 1982; 61(3):237-41. PubMed ID: 6812385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
    Takahashi K; Manabe A; Okada M; Kurioka H; Kanasaki H; Miyazaki K
    Maturitas; 2000 Feb; 34(2):169-77. PubMed ID: 10714912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms.
    Høvik P; Sundsbak HP; Gaasemyr M; Sandvik L
    Maturitas; 1989 Mar; 11(1):75-82. PubMed ID: 2498620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of oestrogens in combination with gestagen on plasma prolactin and FSH levels in post-menopausal women.
    Hagen C; Christiansen C; Christensen MS; Transbøl I
    Acta Endocrinol (Copenh); 1982 Aug; 100(4):486-91. PubMed ID: 6812338
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of Kliogest therapy on serum blood lipids in postmenopausal women].
    Warenik-Szymankiewicz A; Hadaś K; Halerz-Nowakowska B; Korcz-Maciejewska M; Meczekalski B; Dydowicz M; Wiza M
    Ginekol Pol; 1995 Sep; 66(9):541-6. PubMed ID: 8778013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between climacteric symptoms and serum levels of estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone.
    Abe T; Furuhashi N; Yamaya Y; Wada Y; Hoshiai A; Suzuki M
    Am J Obstet Gynecol; 1977 Sep; 129(1):65-7. PubMed ID: 900171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood levels of estradiol, FSH and LH in women with climacteric syndrome--conjugated estrogen therapy].
    Kano T; Nishikawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):189-94. PubMed ID: 6421967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
    Baerug U; Winge T; Nordland G; Faber-Swensson E; Heldaas K; Norling B; Larsen S; Arce JC
    Climacteric; 1998 Sep; 1(3):219-28. PubMed ID: 11907946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
    Mattsson LA; Samsioe G
    Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on climacteric symptoms in relation to ovarian function ageing and psychologic factors].
    Yashiro Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):154-60. PubMed ID: 2498439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
    De Cecco L; Venturini PL; Alibrandi MP; Grondona AL; Morano S; Penna L; Campanella G; Ragni N
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):152-5. PubMed ID: 3922034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
    Grasso A; Baraghini F; Barbieri C; Dalla Vecchia E; Previdi AM; Di Renzo GC; Volpe A
    Maturitas; 1982 Apr; 4(1):19-26. PubMed ID: 6285153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatology and hormonal levels among Thai women with natural menopause.
    Tungphaisal S; Chandeying V; Sutthijumroon S; Krisanapan O
    J Med Assoc Thai; 1992 Dec; 75(12):697-703. PubMed ID: 1308538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
    Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies with clonidine (dixarit) in menopausal women.
    Schindler AE; Müller D; Keller E; Göser R; Runkel F
    Arch Gynecol; 1979; 227(4):341-7. PubMed ID: 518136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators.
    Symons J; Kempfert N; Speroff L
    Obstet Gynecol; 2000 Sep; 96(3):366-72. PubMed ID: 10960627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a new transdermal delivery system for estrogen replacement therapy in postmenopausal women.
    Figueroa-Casas PR; Alfonsin A; Arrighi A; Bluvstein G; Del Castillo R; Goldsman T; Inglesi J; Itala J; Novelli J; Monti C
    Maturitas; 1994 Dec; 20(2-3):139-44. PubMed ID: 7715465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.